Inducible Cre expression through the Rosa 26 locus of recombinant mice
通过重组小鼠的 Rosa 26 位点诱导 Cre 表达
基本信息
- 批准号:7733844
- 负责人:
- 金额:$ 64.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:3&apos Splice SiteAdultAnimal ModelAnimalsBe++ elementBerylliumBreedingBypassCellsDNADNA SequenceDevelopmentDoxycyclineElementsEmbryoEmbryonic DevelopmentGene ExpressionGene Expression RegulationGenerationsGenesGeneticGenetic RecombinationHumanIndividualIntronsLinkMediatingMessenger RNAMethodsModificationMouse StrainsMusMutationNerve TissuePhenotypeRNA SplicingRecombinantsRegulationReporterReporter GenesReportingResponse ElementsRosaSilent MutationSiteSomatic MutationStagingSystemTP53 geneTetanus Helper PeptideTetracyclineTetracycline ControlTetracyclinesTimeTissuesTrans-ActivatorsTranscription CoactivatorTransgenesTransgenic AnimalsTransgenic ModelTransgenic Organismsanalogdesigngene delivery systemgene functionimprovedin vivointerestknockout animalmature animalnovelprenatalpromoterrecombinasesegregationtoolvector
项目摘要
Inducible Cre recombinase systems have been developed to bypass initial lethal phenotypes and to provide access to later embryonic or adult phenotypes. Here we described the generation of a transgenic recombinant mouse that combines a tetracycline dependent switch with generalized Cre recombinase expression by targeting the ubiquitously expressed ROSA26 locus. This transgenic strain (R26rtTA-TRECre) was developed using a universal and simplified gene delivery system designed to facilitate the generation of conditional animals by integrating both elements, the reverse tetracycline controlled trans-activator (rtTA) and rtTA inducible promoter in a single vector. In this transgenic strain, the endogenous ROSA26 promoter drives rtTA expression through a splice acceptor site. The tetracycline inducible promoter or tetracycline response element (TRE), cloned in opposite orientation to the ROSA26 locus and separated from the rtTA element by a 5kb human p53 intron, drives Cre recombinase expression. Crossing these mice with a Cre reporter strain, in which the reporter gene is activated by the elimination of a loxP flanked DNA sequence, showed that Cre DNA mediated recombination was ubiquitously and effectively induced during various prenatal developmental windows upon treatment with a tetracycline analog (doxycycline). Background Cre recombinase expression levels were observed in some tissues in the absence of the inducer, mostly during late embryonic developmental stages. Background recombination levels were low during development and most prominent in nervous tissue. Cre recombinase expression could not be effectively induced in adult animals. While rtTA mRNA levels were high in adult tissues, Cre recombinase mRNA levels remained low after doxycycline treatment. Therefore, the mouse strain described here provides a valuable tool to further analyze the function of genes during specific developmental windows, by allowing the effective inactivation of their function throughout defined stages of embryonic development.
已经开发出可诱导的CRE重组酶系统来绕过初始致命表型并提供后来的胚胎或成人表型。在这里,我们描述了一种转基因重组小鼠的产生,该小鼠通过靶向无处不在表达的ROSA26基因座,将四环素依赖性开关与广义的CRE重组酶表达结合在一起。使用通用和简化的基因递送系统开发了这种转基因菌株(R26RTTA-TRECRE),旨在通过整合这两个元素,反向四环素控制的反式激活器(RTTA)和RTTA诱导启动子在单个载体中促进有条件动物的产生。在这种转基因菌株中,内源性ROSA26启动子通过剪接受体位点驱动RTTA表达。四环素诱导启动子或四环素响应元件(TRE)以与ROSA26基因座相反的方向克隆,并通过5KB人p53内含子与RTTA元素分离,驱动CRE重物组合酶表达。将这些小鼠与CRE报道菌株越过,在该菌株中,通过消除LOXP侧翼DNA序列激活了报告基因,表明在用TetracyCline -Cycline Abalog类似物(DoxyCycline)处理后,在各种产前发育范围内,在各种产前发育窗口中,CRE DNA介导的重组在各种产前发育窗口中被无处不在。在没有诱导剂的情况下,在某些组织中观察到背景CRE重组酶表达水平,主要是在胚胎晚期发育阶段。背景重组水平在发育过程中较低,在神经组织中最突出。在成年动物中无法有效诱导CRE重组酶表达。尽管成人组织中的RTTA mRNA水平较高,但强力霉素治疗后CRE重组酶mRNA水平仍然很低。因此,此处描述的小鼠应变提供了一种有价值的工具,可以通过在胚胎发育的定义阶段有效地失活其功能,从而进一步分析基因的功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Barry J Hoffer其他文献
Barry J Hoffer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Barry J Hoffer', 18)}}的其他基金
Repositioning Gliptins for Parkinson's Disease Treatment
重新定位格列汀治疗帕金森病
- 批准号:
9276809 - 财政年份:2015
- 资助金额:
$ 64.58万 - 项目类别:
Role of GDNF, ER stress and mitochondrial function in effects of acupuncture in models of parkinsonism
GDNF、ER应激和线粒体功能在针刺帕金森病模型中的作用
- 批准号:
8822479 - 财政年份:2014
- 资助金额:
$ 64.58万 - 项目类别:
Role of GDNF, ER stress and mitochondrial function in effects of acupuncture in models of parkinsonism
GDNF、ER应激和线粒体功能在针刺帕金森病模型中的作用
- 批准号:
8912366 - 财政年份:2014
- 资助金额:
$ 64.58万 - 项目类别:
Mechanisms of Exercise-Induced Protection and Rescue in Models of Dopamine Loss
多巴胺丢失模型中运动诱导的保护和救援机制
- 批准号:
8526580 - 财政年份:2011
- 资助金额:
$ 64.58万 - 项目类别:
Mechanisms of Exercise-Induced Protection and Rescue in Models of Dopamine Loss
多巴胺丢失模型中运动诱导的保护和救援机制
- 批准号:
8237234 - 财政年份:2011
- 资助金额:
$ 64.58万 - 项目类别:
Mechanisms of Exercise-Induced Protection and Rescue in Models of Dopamine Loss
多巴胺丢失模型中运动诱导的保护和救援机制
- 批准号:
8716820 - 财政年份:2011
- 资助金额:
$ 64.58万 - 项目类别:
Mechanisms of Exercise-Induced Protection and Rescue in Models of Dopamine Loss
多巴胺丢失模型中运动诱导的保护和救援机制
- 批准号:
8337710 - 财政年份:2011
- 资助金额:
$ 64.58万 - 项目类别:
Studies on CDNF: a new class of neurotrophic proteins
CDNF的研究:一类新的神经营养蛋白
- 批准号:
7733849 - 财政年份:
- 资助金额:
$ 64.58万 - 项目类别:
相似海外基金
Pre-mRNA Processing and Function of Alternatively Spliced Isoforms of TFPI
TFPI 选择性剪接亚型的前 mRNA 加工和功能
- 批准号:
10664506 - 财政年份:2023
- 资助金额:
$ 64.58万 - 项目类别:
Regulation of Splicing During Hematopoietic Stem and Progenitor Cell Formation
造血干细胞和祖细胞形成过程中剪接的调节
- 批准号:
10678816 - 财政年份:2023
- 资助金额:
$ 64.58万 - 项目类别:
Targeting defective spliceosomal pathway in myeloid malignancies
靶向骨髓恶性肿瘤中的缺陷剪接体途径
- 批准号:
10434248 - 财政年份:2022
- 资助金额:
$ 64.58万 - 项目类别:
Targeting defective spliceosomal pathway in myeloid malignancies
靶向骨髓恶性肿瘤中的缺陷剪接体途径
- 批准号:
10555300 - 财政年份:2022
- 资助金额:
$ 64.58万 - 项目类别:
WHY DO MUTATIONS IN IKBKAP CAUSE FAMILIAL DYSAUTONOMIA?
为什么 IKBKAP 突变会导致家族性自主神经失调?
- 批准号:
9381519 - 财政年份:2016
- 资助金额:
$ 64.58万 - 项目类别: